(Q42252471)

19 October 2017

title

Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients (English)

1 reference

19 October 2017

1

1 reference

19 October 2017

M Weisser

11

0 references

Matthias Cavassini

0 references

author name string

G Kralidis

2

1 reference

19 October 2017

N J Mueller

3

1 reference

19 October 2017

H H Hirsch

4

1 reference

19 October 2017

C Garzoni

5

1 reference

19 October 2017

C van Delden

6

1 reference

19 October 2017

C Berger

7

1 reference

19 October 2017

K Boggian

8

1 reference

19 October 2017

A Cusini

9

1 reference

19 October 2017

M T Koller

10

1 reference

19 October 2017

M Pascual

12

1 reference

19 October 2017

P R Meylan

13

1 reference

19 October 2017

Swiss Transplant Cohort Study

14

1 reference

19 October 2017

language of work or name

English

0 references

publication date

5 August 2013

1 reference

American Journal of Transplantation

19 October 2017

published in

1 reference

19 October 2017

volume

13

1 reference

19 October 2017

issue

9

1 reference

19 October 2017

page(s)

2402-2410

1 reference

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

19 October 2017

cites work

1 reference

Late-onset cytomegalovirus disease in patients with solid organ transplant

21 January 2018

1 reference

The 'indirect' effects of cytomegalovirus infection

21 January 2018

1 reference

Viral impact on long-term kidney graft function

21 January 2018

1 reference

Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation

21 January 2018

1 reference

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.

21 January 2018

1 reference

Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients

21 January 2018

1 reference

Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy

21 January 2018

1 reference

Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients

21 January 2018

1 reference

Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial

21 January 2018

1 reference

Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation

21 January 2018

1 reference

Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial

21 January 2018

1 reference

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

21 January 2018

1 reference

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation

21 January 2018

1 reference

Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort

21 January 2018

1 reference

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

21 January 2018

1 reference

Software for fitting nonstandard proportional subdistribution hazards models.

21 January 2018

1 reference

Competing risks and the clinical community: irrelevance or ignorance?

21 January 2018

1 reference

Analyses of cumulative incidence functions via non-parametric multiple imputation

21 January 2018

1 reference

Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation.

21 January 2018

1 reference

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial

21 January 2018

1 reference

Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment.

21 January 2018

1 reference

Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts

21 January 2018

1 reference

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

21 January 2018

1 reference

The impact of early cytomegalovirus infection and disease in renal transplant recipients

21 January 2018

1 reference

Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report

21 January 2018

1 reference

A stringent preemptive protocol reduces cytomegalovirus disease in the first 6 months after kidney transplantation.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.12388

1 reference

19 October 2017

1 reference